Which announcement ?
The last one I saw contained the following
Kazia CEO, Dr James Garner, commented, “this is extremely useful and encouraging data, as we begin to compile regulatory documentation for paxalisib and give shape to its potential commercial approval.
These results give us great confidence that we are administering the drug at the right dose, at the right frequency, and under the correct conditions.
Moreover, the data helps to confirm the approach that we have taken in the GBM AGILE pivotal study.”
He added, “a lot of our efforts at present are focused on assembling the complex package of scientific information that is required to secure FDA approval for any new drug.
Today’s data provides one more piece in that jigsaw. More broadly, the phase II study is drawing to a conclusion, and we expect to be able to share final data in the second half of this year.”
LOOKS PRETTY GOOD TO ME.
I don't think James is the problem, I think it is the pip chasing day traders.
KZA Price at posting:
$1.52 Sentiment: Buy Disclosure: Held
